These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery. Kaida T; Matsuno H; Niwa M; Kozawa O; Miyata H; Uematsu T Thromb Haemost; 1997 Mar; 77(3):562-7. PubMed ID: 9066011 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamic effects of a new antibody glycoprotein IIb/IIIa inhibitor (YM337) in healthy subjects. Harder S; Kirchmaier CM; Krzywanek HJ; Westrup D; Bae JW; Breddin HK Circulation; 1999 Sep; 100(11):1175-81. PubMed ID: 10484537 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: dissociation between anti-platelet aggregatory effect and bleeding time. Matsumoto Y; Takizawa H; Nakama K; Gong X; Yamada Y; Tandon NN; Kambayashi J Thromb Haemost; 2006 Aug; 96(2):167-75. PubMed ID: 16894460 [TBL] [Abstract][Full Text] [Related]
14. Comparative studies on the antiplatelet effects of a humanized anti-platelet glycoprotein IIb/IIIa antibody (YM337) and ReoPro under flow conditions. Kuwahara M; Sugimoto M; Tsuji S; Miyata S; Nishio K; Kaku S; Suzuki K; Kawasaki T; Yoshioka A Thromb Haemost; 1998 Jul; 80(1):28-31. PubMed ID: 9684780 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the antiplatelet agent potential of the whole molecule, F(ab)2 and Fab fragments of humanized anti-GPIIb/IIIa monoclonal antibody in monkeys. Kaku S; Yano S; Kawasaki T; Sakai Y; Suzuki K; Kawamura K; Masuho Y; Satoh N; Takenaka T; Landolfi NF; Co MS Gen Pharmacol; 1996 Apr; 27(3):435-9. PubMed ID: 8723521 [TBL] [Abstract][Full Text] [Related]
16. The Fab fragment of a novel anti-GPVI monoclonal antibody, OM4, reduces in vivo thrombosis without bleeding risk in rats. Li H; Lockyer S; Concepcion A; Gong X; Takizawa H; Guertin M; Matsumoto Y; Kambayashi J; Tandon NN; Liu Y Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1199-205. PubMed ID: 17322098 [TBL] [Abstract][Full Text] [Related]
18. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo. Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595 [TBL] [Abstract][Full Text] [Related]
19. The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons. Fontayne A; Meiring M; Lamprecht S; Roodt J; Demarsin E; Barbeaux P; Deckmyn H Thromb Haemost; 2008 Oct; 100(4):670-7. PubMed ID: 18841291 [TBL] [Abstract][Full Text] [Related]
20. Enhancement by ticlopidine of the inhibitory effect on in vitro platelet aggregation of the glycoprotein IIb/IIIa inhibitor tirofiban. Umemura K; Kondo K; Ikeda Y; Nakashima M Thromb Haemost; 1997 Nov; 78(5):1381-4. PubMed ID: 9408023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]